CCM2 and cerebral cavernous malformation: In CCM animal models, propranolol treatment (1) rescues aberrant development of ccm2 mosaic mutant zebrafish via blocking β1-adrenergic receptors and (2) decreases the multicavernous lesion burden of CCM3 murine models [125,126].